Moderna Cash from Financing (TTM) Analysis

Moderna Inc (MRNA)

113.09 +2.81 (+2.55%) USD | NASDAQ | May 01, 15:18

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2018. Upgrade now.

Date	Value
December 31, 2023	-1.377B
September 30, 2023	-1.706B
June 30, 2023	-2.689B
March 31, 2023	-3.348B
December 31, 2022	-3.448B
September 30, 2022	-3.883B
June 30, 2022	-2.844B
March 31, 2022	-1.541B
December 31, 2021	-873.00M
September 30, 2021	44.00M
June 30, 2021	76.00M

Date	Value
March 31, 2021	1.481B
December 31, 2020	2.033B
September 30, 2020	2.021B
June 30, 2020	2.007B
March 31, 2020	629.71M
December 31, 2019	52.00M
September 30, 2019	596.20M
June 30, 2019	570.96M
March 31, 2019	677.14M
December 31, 2018	1.227B

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-3.883B

Minimum

Sep 2022

2.033B

Maximum

Dec 2020

-642.05M

Average

44.00M

Median

Sep 2021

Cash from Financing (TTM) Benchmarks